News Medical on MSN5d
Scientists analyze virus protein structure to advance RSV vaccinesIn most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) ...
GlobalData on MSN11h
ArkBio concludes dosing for RSV prevention trial in infantsShanghai Ark Biopharmaceutical (ArkBio) has concluded enrolment and dosing for a Phase I trial of fully human monoclonal ...
Respiratory virus activity remained low in the United States last week, with COVID levels continuing to decline, but ...
The oral presentation "Novel Ligand-Targeted Immunotherapy for the Treatment of Human Respiratory Syncytial Virus (RSV)" ...
A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than ...
New COVID-19 research uncovers viral behavior insights, driving innovative treatments with Northwestern Medicine's support.
(“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a ...
Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback